Skip to main content
Clinical Trials/NCT01264562
NCT01264562
Completed
Not Applicable

Cognition in Breast Cancer Patients: The Impact of Cancer-related Stress

Ludwig-Maximilians - University of Munich6 sites in 1 country254 target enrollmentJanuary 2011
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Ludwig-Maximilians - University of Munich
Enrollment
254
Locations
6
Primary Endpoint
Course of cognitive function
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The study will investigate the impact of cancer-related stress and its consequences (acute and posttraumatic stress symptoms, altered cortisol secretion) on cognitive function in breast cancer patients. The hypothesis that stress associated with the cancer diagnosis and the cancer treatment is a major cause of cognitive dysfunction in breast cancer patients shall be evaluated.

Detailed Description

Primary hypothesis: \*The adverse effects of cancer and cancer therapy on cognitive function in breast cancer patients are entirely or partly mediated by stress and the ensuing dysfunction of the HPA-axis. Secondary objectives: * Determining the effect of cancer diagnosis, chemotherapy, disease-related stress, acute stress response, posttraumatic stress disorder, posttraumatic stress symptoms, anxiety, and depression on the HPA-axis in breast cancer patients * Determining the effect of cognitive dysfunction assessed with neuropsychological tests, cancer diagnosis, chemotherapy, disease-related stress, acute stress response, posttraumatic stress disorder, posttraumatic stress symptoms, anxiety, and depression on subjective cognitive function in breast cancer patients * Prevalence of acute stress response, posttraumatic stress disorder and posttraumatic stress symptoms, and extent of cancer-specific stress in breast cancer patients treated with or without chemotherapy

Registry
clinicaltrials.gov
Start Date
January 2011
End Date
October 2014
Last Updated
10 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kerstin Hermelink

Study Principal Investigator

Ludwig-Maximilians - University of Munich

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • not fluent in German
  • substance abuse
  • history of psychosis
  • history of neurologic disorder
  • previous systemic cancer treatment
  • Addison' disease
  • Cushing's syndrome

Outcomes

Primary Outcomes

Course of cognitive function

Time Frame: 12 months

Performance on a battery of cognitive tests

Secondary Outcomes

  • Course of subjective cognitive function(12 months)
  • Course of the stress response(12 months)
  • Course of the HPA-axis function(12 months)

Study Sites (6)

Loading locations...

Similar Trials